Lab Tools

» cancer, flow cytometry and microscopy

Most Recent

image: Screening  with CRISPR

Screening with CRISPR

By | June 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Free Flow

Free Flow

By | December 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Flow Cytometry On-a-Chip

Flow Cytometry On-a-Chip

By | June 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: In Custody

In Custody

By | April 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Picturing Infection

Picturing Infection

By | January 1, 2015

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

4 Comments

image: Sorting Made Simpler

Sorting Made Simpler

By | December 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

1 Comment

image: Capturing Cancer Cells on the Move

Capturing Cancer Cells on the Move

By | April 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

2 Comments

image: Lights, Camera, Action

Lights, Camera, Action

By | January 1, 2014

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

image: Seeing Double

Seeing Double

By | November 1, 2013

Ever-improving CRISPR-based tools are already ripe for large-scale genetic screens.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech